X0708 D LIVE 0001498403 BioLineRx Ltd. 2 HAMA'AYAN STREET MODI'IN L3 ISRAEL 7177871 972-8-642-9100 ISRAEL None BioLineRX, Ltd. Corporation true Philip A. Serlin BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Chief Executive Officer Mali Zeevi BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Chief Financial Officer Ella Sorani BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Chief Development Officer Aharon Schwartz BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Rami Dar BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director BJ Bormann BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Raphael Hofstein BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Avraham Molcho BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Sandra Panem BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Shaoyu Yan BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Gal Cohen BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Biotechnology Decline to Disclose 06b false 2026-08-27 false true true false 0 Chardan Capital Markets LLC 000120128 None None 1 Pennsylvania Plaza, Suite 4800 NEW YORK NY NEW YORK 10119 NY NEW YORK false 3750000 3750000 0 The securities were issued in connection with an offering of (i) 480,696 American depositary shares (ADSs) and 868,225 pre-funded warrants to purchase ADSs in a registered direct offering, and (ii) unregistered warrants to purchase 2,023,382 ADSs. false 1 262500 0 Chardan is also entitled to 1.0% of the gross proceeds as management fee and $50,000 for accountable expenses. 0 The Company intends to use the net proceeds or research and development activities and working capital and general corporate purposes. false BioLineRx Ltd. /s/ Mali Zeevi Mali Zeevi Chief Financial Officer 2026-09-09